Single Postoperative Instillation of Gemcitabine in Patients with Non-muscle-invasive Transitional Cell Carcinoma of the Bladder: A Randomised, Double-blind, Placebo-controlled Phase III Multicentre Study

医学 吉西他滨 泌尿科 移行细胞癌 内科学 安慰剂 膀胱癌 外科 化疗 癌症 病理 替代医学
作者
Andreas Böhle,H. Leyh,Christian Frei,Michael Kühn,Reinhold Tschada,Tobias Pottek,Walter Wagner,Helmut H. Knispel,Wolfgang von Pokrzywnitzki,Ferruh Zorlu,Karin Helsberg,Birgit Lübben,Victoria Soldatenkova,C. Stoffregen,Hartwig Büttner
出处
期刊:European Urology [Elsevier BV]
卷期号:56 (3): 495-503 被引量:107
标识
DOI:10.1016/j.eururo.2009.06.010
摘要

Recurrence prophylaxis with intravesical gemcitabine (GEM) was effective and safe in patients with non-muscle-invasive bladder cancer (NMIBC); efficacy as single-shot instillation remains to be proved. To compare the efficacy of a single GEM instillation versus placebo (PBO) immediately after transurethral resection (TUR) of tumour in patients with histologically confirmed NMIBC (pTa/pT1,G1–3). This was a double-blind, randomised, PBO-controlled study in patients with clinical evidence of primary or recurrent NMIBC (Ta/T1,G1–3). Of 355 patients randomised at 24 urologic centres, 328 underwent TUR and received instillation (92.4%; GEM/PBO: 166/162). In case of nonmalignancy, carcinoma in situ (CIS), ≥pT2 disease, or intraoperative complications, patients were discontinued. We used a single, postoperative 30–40-min instillation of GEM (2000 mg/100 ml of saline) or PBO (100 ml of saline) followed by continuous bladder irrigation for ≥20 h. A second TUR (no instillation) and adjuvant bacillus Calmette-Guérin (BCG) instillations were allowed. Primary outcome was recurrence-free survival (RFS). Secondary outcomes included type of recurrence and adverse events. To detect a difference in RFS, 191 recurrences were required (80% power, log-rank-test, α = 0.050). Two hundred forty-eight patients (69.9%, GEM, PBO: 124, 124) had histologically confirmed pTa/pT1 G1–3 Gx tumour and were eligible for efficacy (GEM: 76.6% male; median age: 65 yr; PBO: 83.1% male; median age: 67 yr). Treatment groups were balanced (pTa: 75.0%, 71.0%; G1–G2: 85.5%, 87.9%; recurrent tumour: 24.2%, 21.0%; BCG: 10.5%, 16.9%). After a median follow-up of 24 mo, there were only 94 recurrences and 11 deaths. The study was terminated early based on predefined decision criteria. RFS was high in both groups (12-mo RFS [95% confidence interval (CI)]: GEM: 77.7% [68.8–84.3]; PBO: 75.3% [66.3–82.3]). There was no significant group difference (hazard ratio [HR]: 0.946 [0.64–1.39], log-rank test, p = 0.777). In this study of NMIBC, the immediate single instillation of GEM 2000 mg/100 ml of saline after TUR was not superior to PBO in terms of RFS. Rigid continuous irrigation and improved TUR/cystoscopy techniques may have contributed to the high RFS in both groups.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
shiizii应助科研通管家采纳,获得10
刚刚
刚刚
刚刚
刚刚
ludong_0应助科研通管家采纳,获得10
刚刚
YeeYee发布了新的文献求助10
刚刚
冷酷的松思完成签到,获得积分10
刚刚
zgt01发布了新的文献求助10
1秒前
zhang完成签到,获得积分10
1秒前
江中完成签到 ,获得积分10
3秒前
3秒前
阿玖完成签到 ,获得积分10
4秒前
jiaolulu发布了新的文献求助10
6秒前
踏雪飞鸿完成签到,获得积分10
7秒前
hannah完成签到,获得积分10
7秒前
songvv发布了新的文献求助10
8秒前
一一一应助Bin_Liu采纳,获得10
9秒前
麻果完成签到,获得积分10
11秒前
OER完成签到,获得积分10
11秒前
伦语完成签到,获得积分20
11秒前
中陆完成签到,获得积分10
12秒前
13秒前
莫西莫西完成签到,获得积分10
15秒前
17秒前
量子星尘发布了新的文献求助10
18秒前
xjh完成签到,获得积分10
18秒前
18秒前
lbnzd8g完成签到,获得积分10
20秒前
中海完成签到,获得积分10
20秒前
Ww完成签到,获得积分10
20秒前
伶俐不二完成签到,获得积分10
20秒前
XIAOJU_U完成签到 ,获得积分10
21秒前
马士全发布了新的文献求助10
22秒前
MQ完成签到,获得积分10
22秒前
单纯血茗发布了新的文献求助10
24秒前
善学以致用应助田南松采纳,获得10
24秒前
不如看海完成签到 ,获得积分10
25秒前
可靠的南露完成签到,获得积分10
26秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038201
求助须知:如何正确求助?哪些是违规求助? 3575940
关于积分的说明 11373987
捐赠科研通 3305747
什么是DOI,文献DOI怎么找? 1819274
邀请新用户注册赠送积分活动 892662
科研通“疑难数据库(出版商)”最低求助积分说明 815022